CNS Drugs Journal Issues Research Articles in May 2022 Edition
May 12, 2022
May 12, 2022
CHAM, Switzerland, May 12 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its May 2022 edition:
Review Articles:
* Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitor . . .
Review Articles:
* Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitor . . .